Schedule 13D ownership disclosure
AUTOLUS THERAPEUTICS LTD
Security class unavailable · CUSIP: 05280R100
Event date: 2018-06-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-213867
- Form type
- SC 13D
- Filer
- Arix Bioscience plc
- CIK
- CIK 1700449
- Filed
- Jul 06, 2018
- Reporting period
- Jun 26, 2018
- Description
- Schedule 13D beneficial ownership